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SUPPLEMENT

Methodology for Knowledge Synthesis of the Management
of Vaccination Pain and Needle Fear
Anna Taddio, PhD,*w C. Meghan McMurtry, PhD,zy Vibhuti Shah, MD,8z
Eugene W. Yoon, MSc,# Elizabeth Uleryk, MLS,w Rebecca Pillai Riddell, PhD,**
Eddy Lang, MD,wwzz Christine T. Chambers, PhD, R Psych,yy88
Melanie Noel, PhD,zz Noni E. MacDonald, MD,##*** and HELPinKids&Adults Team
Background: A knowledge synthesis was undertaken to inform the
development of a revised and expanded clinical practice guideline
about managing vaccination pain in children to include the management of pain across the lifespan and the management of fear in
individuals with high levels of needle fear. This manuscript
describes the methodological details of the knowledge synthesis and
presents the list of included clinical questions, critical and important outcomes, search strategy, and search strategy results.
Methods: The Grading of Assessments, Recommendations,
Development and Evaluation (GRADE) and Cochrane methodologies provided the general framework. The project team voted on
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clinical questions for inclusion and critically important and
important outcomes. A broad search strategy was used to identify
relevant randomized-controlled trials and quasi-randomized-controlled trials. Quality of research evidence was assessed using the
Cochrane risk of bias tool and quality across studies was assessed
using GRADE. Multiple measures of the same construct within
studies (eg, observer-rated and parent-rated infant distress) were
combined before pooling. The standardized mean diﬀerence and
95% conﬁdence intervals (CI) or relative risk and 95% CI was used
to express the eﬀects of an intervention.
Results: Altogether, 55 clinical questions were selected for inclusion
in the knowledge synthesis; 49 pertained to pain management
during vaccine injections and 6 pertained to fear management in
individuals with high levels of needle fear. Pain, fear, and distress
were typically prioritized as critically important outcomes across
clinical questions. The search strategy identiﬁed 136 relevant
studies.
Conclusions: This manuscript describes the methodological details
of a knowledge synthesis about pain management during vaccination and fear management in individuals with high levels of
needle fear. Subsequent manuscripts in this series will present the
results for the included questions.
Key Words: systematic review, knowledge synthesis, meta-analysis,
vaccination, fear management, pain management

(Clin J Pain 2015;31:S12–S19)

A

series of systematic reviews was planned to update the
2010 Help ELiminate Pain in KIDS Team (HELPinKIDS) clinical practice guideline for the management of
acute pain during childhood vaccine injections.1 The decision for a new knowledge synthesis on this topic was
informed by 2 factors: (1) a large number of new published
trials, warranting reexamination of original recommendations; and (2) interest by stakeholder organizations
in expanding the scope of the original guideline to attain a
more comprehensive approach to the topic. These additional domains included the inclusion of adults and the
management of fear in individuals with high levels of needle
fear. As a result of the changes in scope, the team name was
changed to HELPinKids&Adults.
This manuscript describes the methodological details
used to carry out the systematic reviews, including: selection of the clinical question domains and outcomes, search
strategy, data extraction, quality assessment, and data
synthesis approach. It also includes the results for included
clinical questions, critical and important outcomes, and the
number of studies identiﬁed from the search strategy. The
results of the knowledge synthesis of each included question
is presented separately, in other manuscripts in this series,
according to type of intervention examined.
Clin J Pain
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METHODS
The Grading of Assessments, Recommendations,
Development and Evaluation (GRADE)2 and Cochrane
Handbook methodologies3 provided the general framework
for the systematic reviews. A working group including 6
individuals (ie, evidence leads: A.T., C.M.M., V.S., R.P.R.,
C.T.C., M.N.) led by the ﬁrst author (A.T.) was convened
to oversee the knowledge synthesis.

Protocol and Registration
This systematic review was registered on the Prospero
register (registration number: CRD42014013527). The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guideline4 was used to guide reporting.

Eligibility Criteria
Using Appraisal of Guidelines for Research and
Evaluation-II principles (http://www.agreetrust.org) and
GRADE methodology as guidance, HELPinKids&Adults,
an interdisciplinary panel of clinicians, researchers, policy
makers, and consumer stakeholders involved in aspects of
guideline development and implementation, vaccination,
and pain from across Canada identiﬁed clinical questions
for inclusion.
Forty-seven candidate clinical question domains
(including population, intervention, comparison) were initially proposed for inclusion. Questions were identiﬁed
from the prior guideline, clinical practice, and existing
research. An independent electronic vote was carried out to
determine which candidate clinical question domains would
be considered further. A cut-oﬀ of >2/3 majority in favor
of including a clinical question domain was used as the
threshold for preliminary inclusion. Using this method, 37
question domains were retained as preliminary questions.
Outcomes for each preliminary question domain were
then selected by having team members independently vote
on the importance of 13 candidate outcomes identiﬁed by
them (delineated below) using a scoring system of 1 to 9.
Voting was carried out electronically. Consistent with the
GRADE framework, outcomes with a mean score of Z7
were deﬁned as critically important for decision making;
those with a mean score of 4 to 6 were deﬁned as important
and included as outcomes of interest to the review; the
remainder (mean score <4) were not considered further.5
In selecting outcomes, consideration was given to the perspectives of individuals undergoing vaccination, parents of
children undergoing vaccination, and clinicians administering vaccinations; however, the perspective of the individual undergoing vaccination was prioritized to guide
selection.
Modiﬁcations to clinical question domains and outcomes were made after a preliminary review and discussion
of the research evidence at an in-person meeting of the
project team. Several questions were removed due to a lack
of conﬁdence regarding the applicability of the evidence
base to the vaccination context, and others were added to
examine additive eﬀects of combined interventions of
interest and/or alterations in the timing or delivery of the
interventions.

Composition of Clinical Questions—Participants,
Interventions, Comparisons, Outcomes, Study
Designs (PICOS)
Participants included individuals of all ages undergoing
vaccine injections in inpatient and outpatient settings,
Copyright
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including schools, and individuals with high levels of needle
fear. If no data existed for vaccine injections, then the closest
related procedure or context was included (eg, venipuncture
in outpatient clinic). Interventions included single and combination interventions used for vaccine injection pain management (or related procedures/contexts if there were no data
for vaccine injections) including: procedural strategies,
physical strategies, pharmacological strategies, psychological
(and information provision) strategies, and process (education/implementation) strategies. Interventions for the management of fear in individuals with high levels of needle fear
were also included. Comparators included: no treatment control (no documented intervention above usual/routine care) or
other comparators, as speciﬁed by the clinical question.
Cointerventions were allowed depending on the clinical question. The additive beneﬁt of an intervention over another was
also examined, as speciﬁed by the clinical question. Potential
outcomes considered included: pain, fear, distress, preferences
(for individuals undergoing vaccination, parents of children
undergoing vaccination, clinicians administering vaccinations),
satisfaction (individuals, parents, clinicians), fainting, procedure outcomes (duration, success), parent fear, knowledge
about pain interventions (individuals, parents, clinicians), pain
intervention utilization (individuals, parents, clinicians), safety
outcomes, vaccine compliance, and/or memory of pain and/or
fear. Study designs considered included randomized-controlled
trials (RCTs) and quasi-RCTs with between-groups (parallel)
and cross-over designs. Cluster trials were also included.

Information Sources and Search Strategy
The OvidSP platform was used to run the search
strategy in MEDLINE, EMBASE, and PsycINFO databases; EBSCOHost was used for CINAHL and ProQuest
was used for ProQuest Dissertations & Theses Global. The
databases were searched from their date of inception; the
last update was February 26, 2015. No language restrictions
were applied. Search terms used to identify studies for
inclusion were determined by the authors based on their
content expertise in this area in consultation with an academic librarian (E.U.), who conducted the searches. Additional studies were identiﬁed from reference lists of included
studies and by consulting experts working in this topic area.
The titles and abstracts of retrieved citations were imported
into an EndNote library and scanned by 2 reviewers (A.T.,
V.S.). The reviewers identiﬁed citations to be retrieved as
full-text articles, and these were assessed for eligibility by 2
reviewers (A.T., C.M.M.). Reviewers were not blinded to
the authors or settings of the studies in the scanned articles.

Inclusion and Exclusion Criteria
The review included original research articles involving: (1) individuals of all ages; (2) interventions included in
the clinical questions; (3) vaccine injections and/or the
closest related procedure or context to vaccine injections;
and (4) highest level of evidence available (ie, RCTs and
quasi-RCTs). Studies that were published as full reports or
short reports were included, as well as published academic
theses. We excluded published abstracts, letters, commentaries, and editorials.

Data Extraction
Data from eligible studies were extracted and checked
by at least 2 reviewers in customized data extraction forms.
Before extraction, all evidence leads provided feedback
regarding the usability and comprehensiveness of the

2015 Wolters Kluwer Health, Inc. All rights reserved.
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extraction forms. Data forms used an outcome-based
approach, as speciﬁed by the GRADE methodology.6
Reviewers resolved any disagreements through discussion
or, if required, consultation with a third individual (ie, the
project lead and ﬁrst author, A.T.).
Data extracted from each study included: author;
country; year of publication; age of participants; sample
size; design details; procedure and intervention details;
comparison; and critical outcomes. Summary statistics (eg,
means, SDs) and sample sizes were extracted for critically
important and important outcomes for each clinical question by at least 2 reviewers using the data extraction sheet.
Studies including multiple treatment arms could contribute
to several analyses (ie, the same study could provide data
for several clinical questions). Only data from the relevant
treatment arms were included in any particular analysis. If
a study provided multiple arms for 1 analysis, the sample
size was divided by the appropriate number so as not to
double-count individuals within the analysis.
If not provided, summary statistics were estimated
from graphs and/or calculated from medians and ranges or
other parameters (eg, SEs, interquartile ranges, 95% conﬁdence intervals [CIs]) using established formulae7 and
statistical programs (RevMan version 5.2; the Cochrane
Collaboration, Copenhagen, Denmark). If not provided,
sample size was estimated by dividing the total sample size
by the number of groups. When data could not be obtained,
a descriptive summary of the ﬁndings, as reported by the
authors, was included in the review. Data were abstracted
using an intent-to-treat (ITT) approach; however, if ITT
results were not available, a per-protocol approach was
used. Attempts were made to contact study authors by
email in situations whereby additional information was
needed to clarify methods and/or summary statistics.
Steps were undertaken to provide unique identiﬁers for
included studies in the software programs used to carry out
the review (ie, RevMan, GRADEproﬁler). Studies were
identiﬁed using the following notation: “First Author” “Year
of Publication” [eg, Taddio 2014]. If studies contributed to
multiple analyses, then “(#)” was added to enable their discernment [eg, Taddio 2014 (1)]. If the same author published
more than 1 study in the same year, then a lower case letter
was added for subsequent articles [eg, Taddio 2014 a (1)].

Quality of Research Evidence in Individual
Studies
The included trials were not masked to reviewers.
Methodological quality of included studies was assessed by at
least 2 reviewers at the outcome level using the Cochrane risk
of bias tool (https://bmg.cochrane.org/assessing-risk-biasincluded-studies). Domains evaluated included: sequence
generation, allocation concealment, blinding of study participants and personnel, blinding of outcome assessors,
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incomplete outcome data, selective outcome reporting, and
other sources of bias. When available, published studies were
compared with trial registration information to evaluate
selective outcome reporting. Ratings incorporated information from both the published paper and any supplemental
data provided by the authors. Discrepancies were resolved by
consensus and with the assistance of a third reviewer, if
necessary. The results were used to rate the quality of the
evidence and to evaluate heterogeneity in meta-analyses.

Delineation of Outcomes
Pain, fear, and distress were typically prioritized as
critical outcomes; working deﬁnitions for these constructs are
given in Table 1. In a separate manuscript in this supplement,
these constructs are further delineated and explored in the
needle context using a developmental perspective.8 Consistent
with GRADE methodology, critical outcome selection was
inﬂuenced by the available evidence base.9 In the absence of
data for pain due to the inclusion of participants in studies
whereby their self-report is not possible (eg, infants), distress
was the critically important outcome.
The primary assessment method for subjective outcomes (eg, pain, fear) was self-report. Self-reported pain
and fear were typically measured using a Visual Analog
Scale (VAS), Numerical Rating Scale (NRS), or faces scale.
If self-report was not possible (eg, infant unable to provide
self-report), observational measures were used. Observational measures could also be considered if self-report was
potentially unreliable (eg, child younger than 7 y). As
observational methods typically cannot distinguish between
pain and fear, the term used to describe these measures was
distress. Behavioral scales (typically including facial
actions, body movements, and/or cry) or global rating
scales were used for observer-reported distress. Physiological measures reﬂect overall nonspeciﬁc arousal and were
not considered. If onlookers (eg, parents) provided ratings
of their own fear, distress, or anxiety while another individual was undergoing vaccination, this was reported as
fear to maintain consistency in terminology.
Outcomes that were evaluated at multiple timepoints
were analyzed according to the following phases to more
precisely describe the intervention eﬀects: (1) the preprocedure phase, which occurred postintervention but
before vaccine injection(s); (2) the acute phase (within the
ﬁrst minute of needle puncture and vaccine injection); and
(3) the recovery phase (1 to 5 min after vaccine injection(s)).
Outcomes were also assessed over combinations of these
procedure phases (eg, distress during acute and recovery
phases).

Summary Measures and Data Synthesis
Qualitative (descriptive) and quantitative (meta-analytic) data synthesis methods were used. Quantitative

TABLE 1. Definitions Used for Knowledge Synthesis
Pain = Self-rated acute pain (from needle poke and vaccine injection). Delayed pain (hours after injection) was not considered.
Fear = Self-rated negative aﬀect referred to as fear, anxiety, or distress. Fear was separated according to phase of procedure, and could
typically include preprocedural (and postintervention) and acute (from needle poke and vaccine injection) fear.
Distress (ie, pain + fear) = Observer-rated behaviour referred to as distress, pain, fear, or anxiety, whereby the observer was a researcher,
parent, or clinician. Distress was separated according to phase of procedure, and could typically include preprocedural (and
postintervention), acute (0 to 1 min after needle poke and vaccine injection) and recovery (1 to 5 min after needle poke and vaccine
injection).
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syntheses were conducted using RevMan version 5.2
(Cochrane Collaboration). As per the GRADE approach,10
continuous outcome data were combined using the
standardized mean diﬀerence (SMD) with 95% CI. SMD
allowed standardization of results to a uniform scale. The
SMD expresses the size of the intervention eﬀect in each
study relative to the variability observed in that study. For
cross-over trials, continuous data were combined using the
statistical approach described in the Cochrane review by
Pillai Riddell.11 For cluster trials, the numbers provided
were used, without consideration of the intraclass correlation coeﬃcient.
For the purposes of this synthesis, an SMD as low as
0.2, representing a small eﬀect,12 was considered important
as pain from vaccine injections is by nature an iatrogenic
harm of these procedures for which the team agreed that
interventions should be given even if there is limited beneﬁt.
Dichotomous data (eg, presence/absence of pain based on a
predetermined cut-oﬀ value), were combined using relative
risk and 95% CI. A random-eﬀects model was selected for
pooling data.
Within speciﬁc clinical question domains, separate
analyses were planned a priori for diﬀerent age groupings
to account for diﬀerences in the developmental level of
recipients, and/or the interventions and their implementation (eg, timing or delivery method). For example, the eﬀect
of positioning on pain during vaccine injections was
examined separately for neonates who were undergoing
skin-to-skin care during injection (vs. lying supine) and
children who were sitting upright during injection (vs. lying
supine). Age categorizations also considered the existing
evidence base (ie, the age groups for which there was evidence) and typically included; early childhood (0 to 3 y),
childhood (> 3 to 12 y), adolescence (> 12 to 17 y), and
adulthood (Z18 y). Early childhood was further subdivided
into the ﬁrst month of life (neonate), ﬁrst year of life
(infant), the ﬁrst 2 years of life, and the ﬁrst 3 years of life,
as appropriate.
If a study included assessments of the same outcome
measure at multiple timepoints within the same phase of the
procedure (eg, acute distress measured at 15, 30, 45, and
60 s), or multiple outcome measures were used for the same
construct in the same phase (eg, acute distress measured
using VAS and cry duration), including measurement by
proxy (eg, clinician and parent-rated), the data were combined into a single point estimate and associated variance
using established statistical methods13 and an estimated
correlation of 0.25.14 This comprehensive approach to data
synthesis resulted in the ability to include all the data pertaining to critical and important outcomes in the metaanalysis and minimized potential bias from “cherry
picking” outcomes from individual studies. The sample size
used for the meta-analysis included the maximum number
for any single assessment. The discrepancy in the sample
sizes between assessments usually ranged between 1 and 2
participants; hence, this approach was deemed acceptable.
If multiple methods of presentation of the same outcome were included (eg, total score and diﬀerence score from
baseline), only the diﬀerence score from baseline was used for
the meta-analysis. If a study included both nonblinded and
blinded assessments, outcomes were combined for blinded
assessments only. This reduced the potential for a biased
estimate in the meta-analysis. If blinded assessments were not
available for the outcome in individual studies, then nonblinded assessments were used in the meta-analysis. Study
Copyright
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quality ratings reﬂected blinding status. Scores were
standardized to a 0 to 10 scale before pooling; however, in a
minority of instances, outcome data could not be standardized due to missing information regarding the range of the
measure.
Clinical heterogeneity was assessed by noting the differences among studies in the following variables: age group
(participants), country, intervention, comparison, type of
vaccine, injection method, cointerventions (eg, simultaneous
use of other pain-reducing strategies), outcome assessment
methods, and other study-speciﬁc design features.
Statistical heterogeneity was assessed using the I2
index (percentage of total variability due to heterogeneity
between studies) and w2 tests. For I2, the following template
was used to judge the results regarding heterogeneity: 0%
to 40%, may not be important; 30% to 60%, may be
moderate; 50% to 90%, may be substantial; and 75% to
100%, may be considerable. For I2 values of >95%, the
magnitude and accompanying P value from the w2 test were
considered in the overall interpretation. Funnel plots were
performed to assess for the possibility of publication bias if
there were suﬃcient numbers of trials (> 10).3

Quality of Research Evidence Across Studies
As per the GRADE approach, the quality of evidence
from outcomes across studies was assessed. The quality
assessment considered 5 factors: risk of bias (study limitations), inconsistency (heterogeneity of results), indirectness (evidence does not come from direct comparisons of
interest), imprecision (sample size and CI), and publication
bias (trials with positive ﬁndings more likely to be published). The quality of evidence rating for speciﬁc outcomes
was assigned to 4 categories: high, moderate, low, and very
low evidence, all reﬂecting the degree of conﬁdence in the
quantitative measure of beneﬁt or harm suggested by the
systematic review.15 Evidence proﬁles and summary of
ﬁndings tables were created for each clinical question
through the GRADEproﬁler software (version 3.6.1) in
which judgments pertaining to the evaluation of the quality
of evidence were recorded with an extensive array of
explanatory footnotes.

Additional Analyses
Additional analyses were carried out according to
quality and/or study methodology (eg, removal of data
from a study with serious methodological ﬂaw(s) and/or
major diﬀerence in study methodology).

RESULTS
Altogether, 55 clinical questions were included in the
review; they are displayed in Table 2 along with relevant
critically important and important outcomes. Individual
clinical questions were organized into 6 categories: (1)
procedural interventions; (2) physical interventions; (3)
pharmacological interventions; (4) psychological interventions; (5) process interventions; and (6) interventions for
individuals with high levels of needle fear. Pain, fear, and
distress were typically prioritized as critically important
outcomes across clinical questions.
The ﬂow of studies and search strategy used to identify
the relevant literature are displayed in Figure 1 and Supplemental Digital Content, Table 1, http://links.lww.com/
CJP/A182, respectively. Altogether, 82,234 unique citations
were screened and 136 were included in the knowledge

2015 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 2. Clinical Questions and Outcomes

Clinical Questions
Procedural interventions
Should no aspiration be used (rather than aspiration)
during intramuscular vaccine injections in individuals
of all ages?
Should injecting the most painful vaccine last be used
(rather than ﬁrst) during vaccine injections in individuals
of all ages?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in infants
0-1 y?
Should simultaneous injections be used (rather than sequential
injections) during vaccine injections in children >1-10 y?
Should the vastus lateralis be used (rather than the deltoid) as
the site of injection during vaccine injections in infants
0-11 months?
Physical interventions
Should breastfeeding be used during vaccine injections in
children 0-2 y?
If breastfeeding is not used during vaccine injections, should
breastfeeding be used before vaccine injections in children
0-2 y?
Should skin-to-skin contact be used during vaccine injections
in neonates 0-1 month?
Should holding be used (rather than lying supine) during
vaccine injections in children 0-3 y?
If holding is not used during vaccine injections, should a
combined holding intervention (including patting
and/or rocking) be used after vaccine injections in
children 0-3 y?
Should sitting upright be used (rather than lying supine)
during vaccine injections in children >3 y and adults?
Should non-nutritive sucking (using a ﬁnger/thumb, paciﬁer)
be used during vaccine injections in children 0-2 y?
Should manual tactile stimulation be used during vaccine
injections in individuals of all ages?
Should tactile stimulation using an external vibrating device
and cold be used during vaccine injections in children
>3-17 y?
Should warming the vaccine before vaccine injections be used
in individuals of all ages?
Should muscle tension be used for vaccine injections in
children Z7 y and adults with a history of fainting?
Pharmacological interventions
Should topical anesthetics be applied before vaccine injections
in children 0-12 y?

Critical Outcomes*

Important Outcomes

Pain, distress

Procedure outcome, compliance, satisfaction,
preference

Pain, distress

Procedure outcome, compliance, satisfaction,
preference

Distress

Procedure outcome, parent fear, compliance,
preference, satisfaction

Pain, distress

Fear, procedure outcome, parent fear,
compliance, memory, preference, satisfaction
Procedure outcome, safety, compliance,
preference, satisfaction

Distress

Distress
Distress
Distress
Distress
Distress

Pain, fear
Distress
Pain, distress
Pain, fear

Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, parent fear, use of
intervention, compliance, preference, satisfaction
Distress, procedure outcome, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcome, parent fear, use of
intervention, compliance, preference, satisfaction
Fear, procedure outcome, use of intervention,
compliance, preference, satisfaction
Distress, procedure outcome, use of intervention,
compliance, preference, satisfaction

Pain, distress

Preference, satisfaction

Fainting

Pain, distress, fear, procedure outcome,
compliance, memory, preference, satisfaction

Pain, distress, fear

Procedure outcome, safety, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, fear, procedure outcome, safety, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction

Should topical anesthetics be applied before vaccine injections
in adolescents >12 y and adults?

Pain

Should topical anesthetics be used before vaccine injections in
combination with breastfeeding during vaccine injections
(rather than topical anesthetics or breastfeeding alone) in
children 0-2 y?
Should acetaminophen be given before vaccine injections in
individuals of all ages?
Should ibuprofen be given before vaccine injections in
individuals of all ages?
Should sucrose solution be given before vaccine injections in
children 0-2 y?
Should glucose solution be given before vaccine injections in
children 0-2 y?
Should sweet-tasting solutions (sucrose, glucose) be used
before vaccine injections in combination with non-nutritive
sucking (ﬁnger/thumb, paciﬁer) during vaccine injections
(rather than sweet-tasting solutions or non-nutritive sucking
alone) in children 0-2 y?

Distress

Pain, distress

Fear, safety, compliance, preference, satisfaction

Pain, distress

Fear, safety, compliance, preference, satisfaction

Distress

Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction
Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction

Distress
Distress

(Continued )
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TABLE 2. (continued)
Clinical Questions
Should breastfeeding and sweet-tasting solutions (sucrose,
glucose) be combined together before vaccine injections
(rather than breastfeeding or sweet-tasting solutions alone)
in children 0-2 y?
Should vapocoolants be applied before vaccine injections in
children 0-3 y?
Should vapocoolants be applied before vaccine injections in
children >3-17 y?
Should vapocoolants be applied before vaccine injections in
adults?
Psychological interventions
Should a verbal signal of the impending procedure be used
(rather than signal of impending pain) by clinicians during
vaccine injections in individuals of all ages?
Should false suggestion be used during vaccine injections in
individuals of all ages?
Should repeated reassurance be used during vaccine injections
in individuals of all ages?

Critical Outcomes*

Important Outcomes

Distress

Procedure outcome, safety, parent fear, use of
intervention, compliance, preference, satisfaction

Distress

Parent fear, procedure outcomes, safety,
compliance, preference, satisfaction
Distress, fear, parent fear, procedure outcomes,
safety, compliance, memory, preference,
satisfaction
Distress, fear, procedure outcomes, safety,
compliance, memory, preference, satisfaction

Pain
Pain
Pain, distress, fear

Procedure outcomes, parent fear compliance,
memory, preference, satisfaction

Pain, distress, fear

Procedure outcomes, parent fear, compliance,
memory, preference, satisfaction
Procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, use of intervention,
compliance, memory, preference, satisfaction
Distress, procedure outcomes, use of intervention,
compliance, memory, preference, satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, parent fear, use of
intervention, compliance, memory, preference,
satisfaction
Distress, procedure outcomes, use of intervention,
compliance, memory, preference, satisfaction

Pain, distress, fear

Should directed video distraction be used during vaccine
injections in children 0-3 y?

Distress

Should directed toy distraction be used during vaccine
injections in children 0-3 y?

Distress

Should nondirected toy distraction be used during vaccine
injections in children 0-3 y?

Distress

Should verbal distraction be used during vaccine injections in
children >3-12 y?

Pain, fear

Should video distraction be used during vaccine injections in
children >3-12 y?

Pain, fear

Should music distraction be used during vaccine injections in
children >3-12 y?

Pain, fear

Should music distraction be used during vaccine injections in
adolescents >12-17 y?

Pain, fear

Should music distraction be used during vaccine injections in
adults?
Should visual distraction be used during vaccine injections in
adults?
Should breathing with a toy (blowing bubbles, pinwheel) be
used during vaccine injections in children >3-12 y?

Pain, fear
Pain, fear
Pain, fear

Should breathing without a toy (blowing, deep breathing) be
used during vaccine injections in children >3-12 y?

Pain, fear

Should breathing interventions (cough) be used during vaccine
injections in children >3-17 y?

Pain, fear

Should breathing interventions (cough, breath-hold) be used
Pain, fear
during vaccine injections in adults?
Process interventions
Should clinicians administering vaccine injections be educated Use of intervention
about vaccine injection pain management?
Should parents be present during vaccine injections in children Pain, fear, distress
0-10 y?
Should parents be educated about vaccine injection pain
Use of intervention,
management before the day of vaccination (ie, ahead of
pain, fear, distress
time)?

Pain, distress, fear, procedure outcome, parent
fear, compliance, preference, satisfaction
Procedure outcome, parent fear, compliance,
memory, preference, satisfaction
Procedure outcomes, parent fear, knowledge,
compliance, memory, preference, satisfaction
(Continued )
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TABLE 2. (continued)
Clinical Questions

Critical Outcomes*

Should parents be educated about vaccine injection pain
management on the day of vaccination?
Should children >3 y and adults be educated about vaccine
injection pain management on the day of vaccination?

Important Outcomes

Use of intervention,
Procedure outcomes, parent fear, compliance,
pain, fear, distress
memory, preference, satisfaction
Pain, fear
Distress, procedure outcomes, use of intervention,
parent fear, compliance, memory, preference,
satisfaction

Interventions for individuals with high needle fear
Should in vivo exposure-based therapy be used for children
Z7 y with high levels of needle fear?

Fear

Should in vivo exposure-based therapy be used for adults with
high levels of needle fear?
Should multiple session in vivo exposure-based therapy be
used (rather than single session) for children Z7 y and adults
with high levels of needle fear?
Should non in vivo (imaginal) exposure-based therapy be used
for children Z7 y with high levels of needle fear?
Should non in vivo exposure-based therapy be used for adults
with high levels of needle fear?
Should applied tension (exposure and muscle tension) be used
for children Z7 y and adults with high levels of needle fear
and fainting?

Distress, pain, fainting, procedure outcomes,
parent fear, compliance, memory, preference,
satisfaction
Distress, pain, fainting, procedure outcomes,
compliance, memory, preference, satisfaction
Distress, pain, fainting, procedure outcomes,
compliance, memory, preference, satisfaction

Fear
Fear
Fear

Distress, pain, fainting, procedure outcomes,
parent fear, compliance, memory, preference,
satisfaction
Distress, pain, fainting, procedure outcomes,
compliance, memory, preference, satisfaction
Fear, distress, pain, procedure outcomes,
compliance, memory, preference, satisfaction

Fear
Fainting

*Distress is the critical outcome in the absence of data for pain and/or fear in individuals incapable of self-report (eg, infants).

synthesis. Of included studies, 25% were from low-income
and middle-income countries.

DISCUSSION
This manuscript describes the methodological details
of a comprehensive knowledge synthesis undertaken to
inform an update to the 2010 HELPinKIDS clinical practice guideline for vaccination pain management.1 The scope
includes the management of vaccination pain and the
management of fear in individuals with high levels of needle
fear. The process for selecting clinical questions and relevant outcomes are described, as well as methods of data
extraction, quality assessment, and data synthesis. The
included questions and selected critically important and
important outcomes are presented along with the search
strategy and number of included studies.
There are several limitations to our data synthesis
approach that require discussion. Firstly, we combined data
from multiple measures of the same outcome before pooling results across studies and used a standardized measure
of eﬀect (ie, SMD). An alternative (and more typical)
approach is to select results for a single and “best” measure
from each study (ie, the measure with the most robust
validity testing) and to pool data only if the outcome is
measured using the same tool across studies (eg, pain
measured using VAS). We elected to use the former
approach for several reasons, including: (1) it allowed for
inclusion of all the data from a study in the analysis
improving generalizability of the results; (2) resulted in
greater precision in estimates of treatment eﬀect; and (3)
there is currently no rationale for selecting any particular
measure as the “gold standard” method of assessment
across the outcomes included in the knowledge synthesis.
Secondly, we deﬁned the time intervals that bound the
diﬀerent phases of the vaccination procedure (eg, acute
procedural distress was conceptualized as the ﬁrst minute
after vaccine injection). Although this decision was
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informed by prior research in the ﬁeld, at present, the time
intervals which optimally deﬁne the diﬀerent procedural
phases are not known. Moreover, the relative importance of
these phases on the experience of pain is not known. It is
possible that slightly diﬀerent results would be obtained if

114,251
Database
search results

138
Manual Search
Results

114,389
Total retrieved

32,155
Duplicate
references

82,234
References
screened

136
Included

12
with duplicate
data**

82,088
Excluded

FIGURE 1. Guideline flow chart. **The 12 studies in this group
contained data that were either superseded or reanalyzed in the
group of 136 included studies. They were noted as containing
duplicate data.
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only the data from speciﬁc tools were included or the
boundaries for these time epochs were altered.
Strengths of our knowledge synthesis approach
include the use of state-of-the-art methodologies (ie,
GRADE and Cochrane) and a user-centric approach.
Importantly, identiﬁcation of clinical questions and associated outcomes to be included were informed by a broad
group of stakeholders involved in vaccination across the
lifespan; this approach resulted in data that are highly relevant to users. In particular, the inclusion of outcomes
beyond “pain” allows for a more comprehensive synthesis
than previously undertaken in this ﬁeld. Outcomes that
were identiﬁed as important to stakeholders can be used to
inform the selection of outcomes that are included in future
clinical trials. Moreover, aspects of data analysis described
above (ie, combining diﬀerent measures of the same construct, delineation of the eﬀects of an intervention over
time) are unique among knowledge syntheses in similar
domains, and may serve as a template for others under
taking knowledge syntheses. Finally, the inclusion of quasiRCTs allowed for inclusion of more trials, particularly
from low-income and middle-income countries, which
improves generalizability of the ﬁndings.
In subsequent manuscripts in this series, the ﬁndings for
the eﬀects of each intervention included in the individual
clinical questions are presented, including: details regarding
study characteristics of included studies, GRADE evidence
proﬁles and summary of ﬁndings tables, and interpretation of
the results.16–22 Finally, we include a manuscript that outlines
overarching limitations in the included evidence base and
provides recommendations about areas worthy of additional
investigation.23 Separately, we present the 2015 HELPinKids&Adults clinical practice guideline developed from this
knowledge synthesis.24
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